Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide Phase 3 Trial in Japan
jRCT2080223298Phase 3Completed
- Start
- Aug 2016
- Modality
- Small Molecules, Peptides
01
Overview
Phase 3 trial of pasireotide LAR. Started Aug 2016; status: completed.
02
Drugs
pasireotide LAR
Beyond the preview
Go deeper on jRCT2080223298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223298.